Efficient depletion of alloreactive donor T lymphocytes based on expression of two activation‐induced antigens (CD25 and CD69)
Open Access
- 1 June 2000
- journal article
- research article
- Published by Wiley in British Journal of Haematology
- Vol. 109 (3) , 644-651
- https://doi.org/10.1046/j.1365-2141.2000.02074.x
Abstract
T lymphocytes play an important role in allogeneic bone marrow/stem cell transplantation by supporting engraftment and immune recovery. Moreover, donor T cells have been shown to mediate the so‐called graft‐versus‐leukaemia effect and are, therefore, increasingly used for adoptive immunotherapy. However, T‐cell infusions are associated with the risk of a graft‐versus‐host reaction, which may lead to a life‐threatening disease. To overcome this problem, we followed a new strategy for the exclusive depletion of alloreactive cells. We activated allogeneic T cells by cultivation on an adherent cell layer derived from peripheral blood. We then depleted activated cells based on the expression of CD25, CD69 or both activation‐induced antigens using magnetic cell sorting. Mixed lymphocyte culture (MLC) reactions and helper T‐lymphocyte precursor cell frequency (HTLP‐f) assays demonstrated that this technique led to a significant decrease in alloreactivity of ‘donor’ cells, which at the same time preserved reactivity against third‐party cells. The lowest level of alloreactivity was found when CD25 and CD69 antibodies were used together for depletion. This corresponds with our observation that expression of CD25 or CD69 may partially represent different activation pathways. We conclude that ex vivo depletion of CD25‐ and CD69‐expressing alloreactive cells may help to overcome limitations of adoptive immunotherapy.Keywords
This publication has 28 references indexed in Scilit:
- Establishment of an optimised gene transfer protocol for human primary T lymphocytes according to clinical requirementsGene Therapy, 1999
- Selective removal of alloreactive cells from haematopoietic stem cell grafts: graft engineering for GVHD prophylaxisBone Marrow Transplantation, 1999
- Prevention of graft-versus-host disease in high risk patients by depletion of CD4+ and reduction of CD8+ lymphocytes in the marrow graftBone Marrow Transplantation, 1999
- Specific depletion of alloreactive T cells in HLA‐identical siblings: a method for separating graft‐versus‐host and graft‐versus‐leukaemia reactionsBritish Journal of Haematology, 1998
- Selective Immunoaffinity-Based Enrichment of CD34+Cells Transduced with Retroviral Vectors Containing an Intracytoplasmatically Truncated Version of the Human Low-Affinity Nerve Growth Factor Receptor (ΔLNGFR) GeneHuman Gene Therapy, 1997
- Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha.The Journal of Experimental Medicine, 1994
- Homodimeric Murine Interleukin-3 Agonists Indicate that Ligand Dimerization is Important for High-Affinity Receptor Complex FormationGrowth Factors, 1994
- Restoration of Viral Immunity in Immunodeficient Humans by the Adoptive Transfer of T Cell ClonesScience, 1992
- Graft-versus-Host Disease as Adoptive Immunotherapy in Patients with Advanced Hematologic NeoplasmsNew England Journal of Medicine, 1989
- TRANSPLANTATION FOR ACUTE LEUKAEMIA WITH HLA-A AND B NONIDENTICAL PARENTAL MARROW CELLS FRACTIONATED WITH SOYBEAN AGGLUTININ AND SHEEP RED BLOOD CELLSThe Lancet, 1981